In conclusion, we speculate that Smad7 may have mediated the interaction between TGF-β/Smad2/3 and Wnt/β-catenin in the TSF treatment of myocardial fibrosis (Figure 6). Here, SMAD2 is linked to Myocardial fibrosis.